Clinical Trial Update: ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

The document reports a Phase 2 trial evaluating ZD4054 (Zibotentan) or placebo plus chemotherapy in patients with advanced ovarian cancer. The study was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• ZD4054 (Zibotentan) (zibotentan)

Snippet

Sponsor: AstraZeneca | Conditions: Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy | Phase 2 | Status: TERMINATED | Results posted: 2012-06-06